Entheon Biomedical (TSE:ENBI) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Canadian biotech firm Entheon Biomedical is launching a private placement financing to raise up to CDN$300,000 by issuing 3 million units, each consisting of a common share and a warrant. The proceeds will be used for general working capital, providing potential growth opportunities for the company focused on addiction treatment.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.